• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolines

Introduction to 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol (CAS No. 81485-78-1)

2-methyl-1,2,3,4-tetrahydroquinolin-8-ol, identified by the chemical identifier CAS No. 81485-78-1, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal biology. This tetrahydroquinoline derivative exhibits a unique structural framework that has garnered attention for its potential biological activities and mechanistic insights into its interactions with biological targets. The compound’s molecular structure, featuring a methyl-substituted tetrahydroquinoline core with an hydroxyl group at the 8-position, positions it as a valuable scaffold for further chemical modification and pharmacological exploration.

The synthesis and characterization of 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol have been subjects of extensive research due to its relevance in developing novel therapeutic agents. The tetrahydroquinoline scaffold is well-documented for its presence in various bioactive natural products and synthetic molecules, often contributing to their pharmacological properties. The addition of the hydroxyl group at the 8-position introduces a polar moiety that can influence both the solubility and binding affinity of the molecule, making it a promising candidate for drug design.

In recent years, there has been growing interest in tetrahydroquinoline derivatives as potential candidates for treating a range of diseases, including neurological disorders and infectious diseases. The structural motif of 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol suggests that it may interact with biological targets such as enzymes and receptors involved in these pathologies. Preliminary studies have indicated that this compound may possess inhibitory effects on certain enzymes relevant to inflammation and oxidative stress, which are key factors in many chronic diseases.

The chemical properties of 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol make it an attractive intermediate for further derivatization. Researchers have explored various synthetic pathways to modify this core structure, aiming to enhance its pharmacological activity and reduce potential side effects. The hydroxyl group at the 8-position provides multiple opportunities for functionalization, allowing chemists to tailor the molecule’s properties for specific therapeutic applications. For instance, etherification or esterification of this hydroxyl group could lead to derivatives with improved metabolic stability or altered receptor binding profiles.

Advances in computational chemistry have also played a crucial role in understanding the behavior of 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol. Molecular modeling studies have helped predict its binding modes to biological targets and estimate key pharmacokinetic parameters. These simulations provide valuable insights into optimizing the compound’s design before moving to experimental validation. Additionally, high-throughput screening techniques have been employed to rapidly assess the biological activity of this derivative against diverse panels of targets.

The potential therapeutic applications of 2-methyl-1,2,3,4-tetrahydroquinolin-8-ol are further supported by its structural similarity to known bioactive compounds. For example, it shares common features with certain antiviral and anti-inflammatory agents that have demonstrated efficacy in clinical settings. By leveraging these similarities while introducing novel modifications, researchers aim to develop next-generation drugs that combine the best attributes of existing therapies with enhanced efficacy and safety profiles.

In conclusion,2-methyl-1,2,3,4-tetrahydroquinolin-8-ol (CAS No. 81485-78-1) represents a compelling area of research within pharmaceutical chemistry. Its unique structural features and potential biological activities make it a promising candidate for further development into therapeutic agents. As research continues to uncover new insights into its pharmacology and synthetic possibilities,this compound is poised to contribute significantly to advancements in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)